|
Tetrabutylammonium perrhenate 98%
|
|
16385-59-4
|
|
2'(3')-O-(4-Benzoylbenzoyl)adenosine 5'-triphosphate triethylammonium salt >=93%
|
|
112898-15-4
|
|
N,N-Dimethylphenethylamine 98%
|
|
1126-71-2
|
|
(S)-(+)-3-Acetyl-4-benzyl-2-oxazolidinone 99%
|
|
132836-66-9
|
|
Nickel phosphide -100 mesh, 98%
|
|
12035-64-2
|
|
Sodium arsenate heptahydrate
|
|
10048-95-0
|
|
Tylose(R) MH 1000 viscosity 600-1500 mPa.s, 2 % in H2O(20 C)
|
|
9032-42-2
|
|
Tolu balsam FG
|
|
9000-64-0
|
|
Poly[4,4'-methylenebis(phenyl isocyanate)-alt-1,4-butanediol/di(propylene glycol)/polycaprolactone] pellets, MDI-polyester/polyether polyurethane.
|
|
68084-39-9
|
|
1-(5-Methyl-2-thienyl)propan-1-one
|
|
59303-13-8
|
|
N-Methyl-N-(trimethylsilyl)heptafluorobutyramide
|
|
53296-64-3
|
|
Poly(vinyl butyral-co-vinyl alcohol-co-vinyl acetate) average Mw 170,000-250,000, powder
|
|
27360-07-2
|
|
Isatin-5-sulfonic acid sodium salt dihydrate >=98.0%
|
|
207399-16-4
|
|
Thymidine Phosphorylase, recombinant from Escherichia coli recombinant, expressed in E. coli, Suitable for manufacturing of diagnostic kits and reagents, buffered aqueous solution, >=500 units/mL
|
|
9030-23-3
|
|
Pectinesterase from orange peel
|
|
9025-98-3
|
|
2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine perchlorate
|
|
66729-78-0
|
|
Antithrombin III from human plasma lyophilized powder, >=95% (SDS-PAGE)
|
|
90170-80-2
|
|
Hydrazine sulfate-15N2 98 atom % 15N
|
|
88491-70-7
|
|
Plasminogen
|
|
9001-91-6
|
|
Nitric acid, europium(3+) salt, pentahydrate
|
|
63026-01-7
|
|
beta-Glucanase 2, thermostable recombinant, expressed in E. coli, >=90% (SDS-PAGE)
|
|
62213-14-3
|
|
Polyoxyethylene (10) tridecyl ether mixture of C11 to C14 iso-alkyl ethers with C13 iso-alkyl predominating
|
|
78330-21-9
|
|
(+)-3-(Trifluoroacetyl)camphor 98%
|
|
51800-98-7
|
|
Tri-tert-butyl borate 98%
|
|
7397-43-5
|
|
MANGANESE(III) FLUORIDE
|
|
7783-53-1
|
|
Poly[trimethylolpropane/di(propylene glycol)-alt-adipic acid/phthalic anhydride], polyol average Mn ~500
|
|
68133-07-3
|
|
Adenosine 3',5'-diphosphate disodium salt >=96%
|
|
75431-54-8
|
|
3-(Trimethylsilyl)-1-propanol 97%
|
|
2917-47-7
|
|
poly(propylene glycol-block-peg-block-ppg bis(2-A
|
|
65605-36-9
|
|
2-Methylbutyryl chloride 97%
|
|
57526-28-0
|
|
2-Methylpyrimidine 97%
|
|
5053-43-0
|
|
Poly(N-isopropylacrylamide) Mn ~40,000
|
|
25189-55-3
|
|
Polyethylenimine, 80% ethoxylated solution 37 wt. % in H2O
|
|
26658-46-8
|
|
Poly(ethylene-co-propylene-co-5-methylene-2-norbornene) ethylene 50 wt. %
|
|
25038-36-2
|
|
4-(3-Phenylpropyl)pyridine 97%
|
|
2057-49-0
|
|
2'-Iodoacetanilide >=97.0% (HPLC)
|
|
19591-17-4
|
|
Sulforhodamine G Dye content 60 %
|
|
5873-16-5
|
|
Nicotinamide guanine dinucleotide sodium salt phospodiesterase and ADP-ribosyl cyclase substrate
|
|
5624-35-1
|
|
4-Ethoxybenzamide 97%
|
|
55836-71-0
|
|
Dimethirimol PESTANAL(R), analytical standard
|
|
5221-53-4
|
|
Guanosine 5'-diphosphate sodium salt Type I, >=96% (HPLC)
|
|
43139-22-6
|
|
Polyinosinic-polycytidylic acid sodium salt gamma-irradiated
|
|
42424-50-0
|
|
N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)aniline,phosphoric acid
|
|
154-68-7
|
|
N-Methyldibutylamine 98%
|
|
3405-45-6
|
|
Indoxyl phosphate disodium salt crystalline
|
|
3318-43-2
|
|
Sodium 2-(4-isobutylphenyl)propanoate
|
|
31121-93-4
|
|
Diisopropyl chlorophosphate 97%
|
|
2574-25-6
|
|
Poly(2-ethylhexyl methacrylate) solution average Mw ~123,000 by GPC, in toluene
|
|
25719-51-1
|
|
Orotic acid potassium salt >=98%
|
|
24598-73-0
|
|
Thallium(III) trifluoroacetate technical grade
|
|
23586-53-0
|
|
N-(2-Hydroxypropyl)-2-methyl-prop-2-enamide
|
|
21442-01-3
|
|
Dihydromyrcenol >=99%
|
|
18479-58-8
|
|
IR-1061 Dye content 80 %
|
|
155614-01-0
|
|
Ac-YVAD-cmk >=95% (HPLC)
|
|
178603-78-6
|
|
Chloramine-T hydrate 95%
|
|
149358-73-6
|
|
5-Bromo-4-chloro-3-indolyl phosphate dipotassium salt phosphatase substrate
|
|
102185-49-9
|
|
Aluminum chloride hydrate 99.999% trace metals basis
|
|
10124-27-3
|
|
5'-(2,4,6-Triphenylpyridin-1-ium-1-yl)-[1,1':3',1''-terphenyl]-2'-olate
|
|
10081-39-7
|
|
4-(N-[2,4-Diamino-6-pteridinylmethyl]amino)benzoic acid sodium salt >=95% (TLC)
|
|
100929-45-1
|
|
alpha-Mannosidase from Canavalia ensiformis (Jack bean) ammonium sulfate suspension, >=15 units/mg protein (biuret)
|
|
9025-42-7
|
|
[2,6-Dichloro-4-(trifluoromethyl)phenyl]hydrazine 98%
|
|
86398-94-9
|
|
Gly-His-Lys acetate salt >=97% (TLC)
|
|
72957-37-0
|
|
1,3-Bis(4-nitrophenyl)urea 97%
|
|
587-90-6
|
|
Direct Red 23 Dye content 30 %
|
|
3441-14-3
|
|
|
(Dansylaminoethyl)顱tri顱methyl顱ammonium perchlorate
|
33423-98-2
|
|
Tris(dimethylamido)aluminum(III)
|
|
32093-39-3
|
|
Poly(styrene-alt-maleic acid) sodium salt solution 13 wt. % in H2O
|
|
25736-61-2
|
|
Sodium formate-13C 99 atom % 13C
|
|
23102-86-5
|
|
(-)-Dihydrocarveol mixture of isomers, >=95.0% (sum of enantiomers, GC)
|
|
20549-47-7
|
|
1,3-Adamantanediacetic acid 97%
|
|
17768-28-4
|
|
Cyclopentadienyllithium 97%
|
|
16733-97-4
|
|
copper oxychloride
|
|
1332-40-7
|
|
Mercuric trifluoroacetate
|
|
13257-51-7
|
|
Tris(cyclopentadienyl)yttrium(III) 99.9% trace metals basis
|
|
1294-07-1
|
|
Sulfobromophthalein Sodium
|
|
123359-42-2
|
|
alpha-Phellandrene stabilized
|
|
99-83-2
|
|
Trehalase from porcine kidney buffered aqueous glycerol solution, >=1.0 units/mg protein
|
|
9025-52-9
|
|
Heparinase I
|
|
9025-39-2
|
|
Benz[b]anthracene sublimed grade, 99.99% trace metals basis
|
|
92-24-0
|
|
Cadmium acetate hydrate >=99.99% trace metals basis
|
|
89759-80-8
|
|
beta-Nicotinamide adenine dinucleotide lithium salt from Saccharomyces cerevisiae >=95%
|
|
64417-72-7
|
|
Quinalizarin >=95% (HPLC)
|
|
81-61-8
|
|
BTBP
|
|
83054-80-2
|
|
Thyme oil white, FCC, FG
|
|
8007-46-3
|
|
4-Methylumbelliferone sodium salt >=98% (HPLC), crystalline
|
|
5980-33-6
|
|
Tetradecylphosphonic acid 97%
|
|
4671-75-4
|
|
Poly(dimethylsiloxane), vinyl terminated average Mw ~25,000, viscosity 850-1,150 cSt (25 C)(lit.)
|
|
68083-19-2
|
|
Tetrakis(trimethylsilyl)silane >=97.0%
|
|
4098-98-0
|
|
Ethylenediamine tetrakis(ethoxylate-block-propoxylate) tetrol average Mn ~7,200
|
|
26316-40-5
|
|
Sodium L-lactate-13C3 solution 45-55 % (w/w) in H2O, >=99 atom % 13C, >=98% (CP), >=98% (Chiral purity, HPLC)
|
|
201595-71-3
|
|
Silver perchlorate monohydrate 99.999% trace metals basis
|
|
14242-05-8
|
|
Sodium selenide
|
|
1313-85-5
|
|
Calcium 2-ethylhexanoate 98%
|
|
136-51-6
|
|
4-Methylbenzenethiol sodium salt 98%
|
|
10486-08-5
|
|
Sodium oxide 80%
|
|
1313-59-3
|
|
2,8,9-Trimethyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane
|
|
120666-13-9
|
|
Choline hydroxide solution 46 wt. % in H2O
|
|
123-41-1
|
|
Magnesium aluminate, spinel nanopowder, <50 nm particle size (BET)
|
|
12068-51-8
|
|
N,N,N',N'-Tetramethyl-1,4-butanediamine 98%
|
|
111-51-3
|
|
Silver perchlorate anhydrous, 97%
|
|
7783-93-9
|